Trial
NCT04373369
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
Xcovery Holdings, Inc.
Condition
Extensive-stage Small Cell Lung Cancer
Intervention
Vorolanib
Why stopped
Insufficient Funding/Staff
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-03